课题基金 / 基金详情

Research Capacity Core

Research Capacity Core
研究能力核心
批准号:
10708298
负责人:
JOSIAH OCHIENG
金额:
$5.2万
依托单位:
依托单位国家:
美国
项目类别:
财政年份:
1997
资助国家:
美国
项目状态:
未结题
起止时间:
1997-09-30 至 2027-05-31

项目摘要

项目成果

JOSIAH OCHIENG的其他基金

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
Project Summary. The overarching goal of Meharry RCMI Research Capacity Core (MRRCC) is to increase the number of funded investigators at Meharry Medical College. To this end, RCMI has equipped and staffed MRRCC with the latest state of the art biomedical instrumentation that enables our investigators to compete on equal footing with investigators from research intensive institutions like Vanderbilt University. MRRCC Core directors have also established a close working relationship with their counterparts at Vanderbilt University such that our investigators are able to access equipment at Vanderbilt that they may need but not currently available at Meharry. For example, our investigators can access and utilize electron microscope at Vanderbilt for their imaging needs due to such arrangements (see letter of support). During the current funding cycle of RCMI, our investigators were able to obtain R01, R21, SC1 and U54-Cancer investigator-initiated funding based on the data generated in MRRCC. These non-RCMI grants that were obtained with the help of MRRCC totaled more than $ 11,000,000. MRRCC has also fostered collaboration among our investigators. For example, during the current RCMI funding cycle, 314 basic science grant applications collaborated with at least one of the 5 MRRCC cores. Specifically, 65 applications collaborated with one core, 50 with 2 cores, 54 with 3 cores, 37 with 4 cores and 8 collaborated with all the 5 cores. We have 2 broad specific aims for MRRCC in the current application: Aim 1. Expand core services and resources. We will purchase with institutional funds an OpenSPR system for protein-protein interactions in real time and Seahorse for metabolomics studies. As funds become available, we will continue to provide new instrumentation based on our user’s needs. We will establish a new Genomics Data Core. This core will provide Next Generation Sequencing (NGS) data analysis, data mining, AI/ML, and visualization through development of genomic databases and state-of-the-art data-access portal. Lastly we will establish Gene Editing Services. The new core service will help users with the design of CRISPR/Cas9 experimental protocols, perform transfection/infection, determine CRISPR efficiency, clone positive cells, and evaluate on/off-targets efficiency. Aim 2. Continue to provide high quality service. The services we provide are deemed necessary for generating preliminary data for grants, publishing manuscripts in high impact journals, and enabling acquisition of extramural grant support. We will enhance business operations. We are establishing direct connectivity with our Office of Information Technology (OIT) to provide seamless data tracking and improve cost recovery by connecting within institutional-level systems. We will also enhance interconnectivity within the MRRCC Sub-Cores, Meharry research departments, and the national RCMI network. We will enhance cost recovery efforts by requiring funded investigators to budget at least $ 2,000 per year for services that they will get from MRRCC.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Analysis of Serum Exsomes in Patients with Colorectal and Breast Cancer
  • 批准号:
    8261513
  • 项目类别:
  • 资助金额:
    $7.68万
  • 财政年份:
    2011
  • 负责人:
    JOSIAH OCHIENG
  • 依托单位:
Project 2 Fetuin-A in Prostate Cancer
  • 批准号:
    10327934
  • 项目类别:
  • 资助金额:
    $18.97万
  • 财政年份:
    2011
  • 负责人:
    JOSIAH OCHIENG
  • 依托单位:
Project 2 Fetuin-A in Prostate Cancer
  • 批准号:
    10705093
  • 项目类别:
  • 资助金额:
    $22.57万
  • 财政年份:
    2011
  • 负责人:
    JOSIAH OCHIENG
  • 依托单位:
Project 2 Fetuin-A in Prostate Cancer
  • 批准号:
    10493424
  • 项目类别:
  • 资助金额:
    $22.57万
  • 财政年份:
    2011
  • 负责人:
    JOSIAH OCHIENG
  • 依托单位:
海外基金